Literature DB >> 15940319

[Specialised short-term wards in nursing homes--the Trondheim model].

Helge Garåsen1, Stein Kaasa, Tove Røsstad, Peder Broen.   

Abstract

BACKGROUND: The health sector faces major challenges as a consequence of the elderly constituting a growing proportion of the population. Doctors at all levels will need to acquire the skills needed for dealing with patients with multiple and complex conditions, and hospitals will need to be dynamic in dealing with patients with acute and curable diseases as well as with the elderly and chronically ill. There is a considerable professional gap between community care services and services offered by the general hospitals.
MATERIAL AND METHODS: In the City of Trondheim, Norway, the community care and hospital services have analysed the challenges they share and what they can do to make the "chain of care" better for those patients that are the most in need of coordinated efforts. One initiative is two short-term units specialising in treatment and care at an intermediary level between ordinary nursing homes and hospitals.
RESULTS: In 2003, 275 patients were admitted to the intermediary care department in Søbstad nursing home, and at Havstein nursing home 79 patients were admitted to its palliative care department. The operating costs in these nursing homes are higher than in traditional units, but far lower than in hospitals. We suggest that these specialised units represent a good solution, professionally as well as financially.

Entities:  

Mesh:

Year:  2005        PMID: 15940319

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  Promoting coordination in Norwegian health care.

Authors:  Tor Inge Romøren; Dag Olaf Torjesen; Brynjar Landmark
Journal:  Int J Integr Care       Date:  2011-10-07       Impact factor: 5.120

2.  Intermediate care at a community hospital as an alternative to prolonged general hospital care for elderly patients: a randomised controlled trial.

Authors:  Helge Garåsen; Rolf Windspoll; Roar Johnsen
Journal:  BMC Public Health       Date:  2007-05-02       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.